dallas semaglutide constipation class action gastrointestinal obstruction in Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial - Kushner - 2025 dallas semaglutide attorney law firm

J., Hatfield, D

Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, Kuchibhotla U, Moyers JS, Benson CT, Gimeno RE, DAlessio DA, Haupt A

Nausea is the most common gastrointestinal side effect, affecting 44% of patients

Characterization of Undiscovered miRNA Involved in Tumor Necrosis Factor Alpha-Induced Atrophy in Mouse Skeletal Muscle Cell Line

Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study

Reconstituted KPV peptide stored at room temperature (2025C) for 1216 hours loses 1020% potencya degradation magnitude that invalidates dose-response data and introduces uncontrolled variability into multi-day protocols